Cargando…
The Hypoglycemic Effect of JinQi Jiangtang Tablets Is Partially Dependent on the Palmatine-Induced Activation of the Fibroblast Growth Factor Receptor 1 Signaling Pathway
JinQi Jiangtang tablet (JQJTT) is a Chinese patent medicine that has been shown to be beneficial for patients with diabetes both preclinically and clinically; however, the molecular mechanism underlying the effects of JQJTT remains unclear. In this study, surface plasmon resonance fishing was employ...
Autores principales: | Li, Siming, Li, Xiaoling, Wang, HeMeng, Jia, Xinhang, Mao, Haoyang, Dong, Fangxin, Zhao, Tingting, Gao, Yuan, Zhang, Chen, Bai, Ruisong, Liu, Ruihao, Yan, Lijun, Ji, Yubin, Zhang, Na, Wang, Wenfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354937/ https://www.ncbi.nlm.nih.gov/pubmed/35935824 http://dx.doi.org/10.3389/fphar.2022.895724 |
Ejemplares similares
-
JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial
por: Cao, Hongbo, et al.
Publicado: (2010) -
JinQi Jiangtang Tablet Regulates Gut Microbiota and Improve Insulin Sensitivity in Type 2 Diabetes Mice
por: Cao, Ying, et al.
Publicado: (2019) -
The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design
por: Sun, Xiao, et al.
Publicado: (2015) -
Renoprotective effect of JinQi-JiangTang tablet on high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats
por: Jiang, Bingjie, et al.
Publicado: (2018) -
Development and Validation of an UPLC-MS/MS Method for Pharmacokinetic Comparison of Five Alkaloids from JinQi Jiangtang Tablets and Its Monarch Drug Coptidis Rhizoma
por: Sun, Lili, et al.
Publicado: (2017)